1577 related articles for article (PubMed ID: 31758238)
1. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.
Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J
Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238
[TBL] [Abstract][Full Text] [Related]
2. Scutellariae Radix and Coptidis Rhizoma Improve Glucose and Lipid Metabolism in T2DM Rats via Regulation of the Metabolic Profiling and MAPK/PI3K/Akt Signaling Pathway.
Cui X; Qian DW; Jiang S; Shang EX; Zhu ZH; Duan JA
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453687
[No Abstract] [Full Text] [Related]
3. Amelioration of hyperglycaemia and hyperlipidaemia by adjusting the interplay between gut microbiota and bile acid metabolism: Radix Scutellariae as a case.
Zhao L; Ma P; Peng Y; Wang M; Peng C; Zhang Y; Li X
Phytomedicine; 2021 Mar; 83():153477. PubMed ID: 33545549
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of Coptidis Rhizoma on the intestinal absorption and metabolism of Scutellariae Radix.
Zheng W; Sun G; Chen J; Li Z; Zhang T; Wei G; Wang H; Sun X; Zhang Z; Zhao W; Ma P; Zhang Y; Zhang C
J Ethnopharmacol; 2021 Apr; 270():113785. PubMed ID: 33422653
[TBL] [Abstract][Full Text] [Related]
5. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
6. Integrated gut microbiota and fecal metabolomics reveal the renoprotective effect of Rehmanniae Radix Preparata and Corni Fructus on adenine-induced CKD rats.
Zhang ZM; Yang L; Wan Y; Liu C; Jiang S; Shang EX; Duan JA
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1174():122728. PubMed ID: 33975272
[TBL] [Abstract][Full Text] [Related]
7. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
8. UPLC-Q-TOF/MS based fecal metabolomics reveals the potential anti-diabetic effect of Xiexin Decoction on T2DM rats.
Zhang ZM; Chen MJ; Zou JF; Jiang S; Shang EX; Qian DW; Duan JA
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Apr; 1173():122683. PubMed ID: 33857887
[TBL] [Abstract][Full Text] [Related]
9. The water extract of Radix scutellariae, its total flavonoids and baicalin inhibited CYP7A1 expression, improved bile acid, and glycolipid metabolism in T2DM mice.
Yan X; Zhang Y; Peng Y; Li X
J Ethnopharmacol; 2022 Jul; 293():115238. PubMed ID: 35351576
[TBL] [Abstract][Full Text] [Related]
10. Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota.
Wei X; Tao J; Xiao S; Jiang S; Shang E; Zhu Z; Qian D; Duan J
Sci Rep; 2018 Feb; 8(1):3685. PubMed ID: 29487347
[TBL] [Abstract][Full Text] [Related]
11. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
[TBL] [Abstract][Full Text] [Related]
12. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism.
Xiao S; Zhang Z; Chen M; Zou J; Jiang S; Qian D; Duan J
J Ethnopharmacol; 2019 Sep; 241():112032. PubMed ID: 31220598
[TBL] [Abstract][Full Text] [Related]
13. Regulating the gut microbiota and SCFAs in the faeces of T2DM rats should be one of antidiabetic mechanisms of mogrosides in the fruits of Siraitia grosvenorii.
Zhang Y; Peng Y; Zhao L; Zhou G; Li X
J Ethnopharmacol; 2021 Jun; 274():114033. PubMed ID: 33741440
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of the components compatibility of Scutellariae Radix and Coptidis Rhizoma on mice with hyperlipidemia by regulating the Cyp4a family.
Gao Y; Sun YY; Bai D; Wu XX
J Ethnopharmacol; 2024 Sep; 331():118263. PubMed ID: 38677575
[TBL] [Abstract][Full Text] [Related]
15. Lizhong decoction ameliorates ulcerative colitis in mice via modulating gut microbiota and its metabolites.
Zou J; Shen Y; Chen M; Zhang Z; Xiao S; Liu C; Wan Y; Yang L; Jiang S; Shang E; Qian D; Duan J
Appl Microbiol Biotechnol; 2020 Jul; 104(13):5999-6012. PubMed ID: 32418127
[TBL] [Abstract][Full Text] [Related]
16. An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from
Shao J; Liu Y; Wang H; Luo Y; Chen L
Oxid Med Cell Longev; 2020; 2020():1805418. PubMed ID: 32566075
[TBL] [Abstract][Full Text] [Related]
17. Raw and wine processed Schisandra chinensis attenuate anxiety like behavior via modulating gut microbiota and lipid metabolism pathway.
Song Y; Shan B; Zeng S; Zhang J; Jin C; Liao Z; Wang T; Zeng Q; He H; Wei F; Ai Z; Su D
J Ethnopharmacol; 2021 Feb; 266():113426. PubMed ID: 33007392
[TBL] [Abstract][Full Text] [Related]
18. PuRenDan alleviates type 2 diabetes mellitus symptoms by modulating the gut microbiota and its metabolites.
Ma X; Qiu Y; Mao M; Lu B; Zhao H; Pang Z; Li S
J Ethnopharmacol; 2024 Mar; 322():117627. PubMed ID: 38147943
[TBL] [Abstract][Full Text] [Related]
19. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
Yao Y; Chen H; Yan L; Wang W; Wang D
Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
[TBL] [Abstract][Full Text] [Related]
20. Proteomics approach to analyze protein profiling related with ADME/Tox in rat treated with Scutellariae radix and Coptidis rhizoma as well as their compatibility.
Miao Q; Zhao YY; Miao PP; Chen N; Yan XH; Guo CE; Chen HY; Zhang YJ
J Ethnopharmacol; 2015 Sep; 173():241-50. PubMed ID: 26232629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
